BLRX•benzinga•
BioLineRx Ltd., Merck Granted U.S. Patent #12291570 Treatment of metastatic pancreatic adenocarcinoma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga